Trenbolone Acetate 100mg/mL is a short ester injectable anabolic formulation in MCT oil supplied in a 10mL vial. Manufactured for consistency, stability, and research applications.
Format10mL Vial
Concentration100mg/mL
CarrierMCT Oil
Pay with Interac e-Transfer or Crypto
HPLC verified. COA on file for this batch
Ships from within Canada; No Customs
Discreet plain packaging; always
24h dispatch; Tracked Delivery
Trenbolone Acetate is the shortest acting Trenbolone variant, delivering the same base compound as Trenbolone Enanthate and Parabolan (Hexahydrobenzylcarbonate) through a rapid release acetate ester with a half life of approximately 2–3 days. CSD’s formulation delivers 100mg/mL in a 10mL multi dose vial using MCT (medium chain triglyceride) oil as the carrier base; a practical carrier choice for a compound requiring every other day administration, where MCT oil’s ultra low viscosity minimizes injection site discomfort across the frequent administration schedule that short acting Trenbolone protocols demand.
The acetate ester’s short half life requires every other day administration in documented research protocols to maintain stable blood concentration levels. A more demanding schedule than the twice weekly requirement of Trenbolone Enanthate, but one that offers a meaningful research advantage in return. Trenbolone Acetate clears the system significantly faster upon discontinuation than either the enanthate or hexahydrobenzylcarbonate variants, providing researchers with greater control over the active window and faster washout when protocol adjustments are required. This rapid clearance makes it the preferred starting point in research protocols examining individual response to Trenbolone compounds.
CSD stocks Trenbolone Acetate across multiple formats, this 10mL MCT oil vial alongside a 10 x 1mL cottonseed oil ampoule presentation and carries all three Trenbolone ester variants including Trenbolone Enanthate and Parabolan, allowing researchers to source complete Trenbolone ester comparison sets from a single verified Canadian supplier. The base compound characteristics remain consistent across all Trenbolone variants approximately five times the androgen receptor binding affinity of testosterone, no aromatization, and progesterone receptor interaction with ester selection and carrier representing the primary differentiating variables between formulations.
Every batch of CSD’s Trenbolone Acetate is third party lab tested for concentration accuracy and purity prior to release, with COA documentation available on request. Canada Steroid Depot has supplied Canadian customers with consistently verified, accurately dosed compounds for years, and our Trenbolone range remains among the most requested products in our injectable lineup. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.
Store at room temperature away from direct light and heat. Do not freeze. Intended for research purposes only.
Commonly researched alongside a testosterone base compound and a prolactin management agent. Browse CSD’s full injectable range and PCT compounds for complete protocol sourcing.
Trenbolone Acetate is the short acting ester of Trenbolone, a 19-nortestosterone derivative with an anabolic to androgenic ratio of 500:500 compared to testosterone's 100:100, making it one of the most potent anabolic compounds in the research catalogue. It does not aromatize to estrogen, binds the androgen receptor with approximately 5x the affinity of testosterone, and demonstrates strong progestin activity through progesterone receptor binding. It is researched for lean mass accretion, fat loss, vascularity, muscle hardness, strength enhancement, and nutrient partitioning, one of the most extensively studied compounds in competitive body composition research contexts.
The 10mL multi dose vial format offers greater dosing flexibility than single use ampoules, researchers can draw any volume per injection without being locked into fixed 1mL ampoule doses. This allows precise titration of lower doses such as 50mg (0.5mL) or 75mg (0.75mL) per EOD injection for researchers beginning a protocol at conservative doses before escalating. The MCT oil carrier further enhances flexibility, its very low viscosity allows comfortable administration through 25–27 gauge needles, reducing injection site trauma during the frequent EOD administration schedule required for Trenbolone Acetate.
Due to its 2–3 day half-life, Trenbolone Acetate requires every other day (EOD) administration; Monday, Wednesday, Friday, Sunday being the most common research schedule. Common research doses range from 50–100mg per injection (150–300mg per week total). At 100mg/mL, a 0.5mL EOD injection delivers 50mg and a 1mL injection delivers 100mg. The multi dose vial format makes precise partial mL dosing straightforward. This 10mL vial provides sufficient compound for 10–20 EOD injections depending on per injection dose.
Prolactin management with Cabergoline (0.25–0.5mg twice weekly) is the primary ancillary requirement for Trenbolone Acetate research due to its strong progestin activity through progesterone receptor binding which can elevate prolactin particularly in the presence of estrogen. An aromatase inhibitor for estrogen management from any concurrent testosterone base is also recommended. Cardiovascular monitoring is important; Trenbolone has the most severe negative impact on lipid profiles of any commonly researched anabolic compound, significantly reducing HDL and elevating LDL.
Yes! This batch has been independently HPLC tested by an accredited third party laboratory confirming concentration accuracy at 100mg/mL and compound identity as Trenbolone Acetate. A certificate of analysis is available.
